|

VIR-5525 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AMX-525

Pipeline

Phase 1: 1

Top Sponsors

  • Vir Biotechnology, Inc.1

Indications

  • EGFR Positive Solid Tumors1
  • eGFR1
  • Solid Tumor Malignancies1
  • Cancer1

Scottsdale, Arizona1 trial

Safety and Preliminary Efficacy of VIR-5525 and VIR-5525 + Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Honor Health Research Institute

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.